KYTX: Transformative cell therapy shows strong efficacy and safety, targeting near-term approval and launch
Cell therapy for autoimmune diseases is advancing rapidly, with miv-cel showing strong efficacy and safety in stiff person syndrome and myasthenia gravis. Regulatory progress, robust clinical data, and a focused commercialization strategy position the therapy for near-term launch and broader pipeli…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.